ARCHIVES

Study: Delaying ADT Until Symptoms Appear Can Be Safe in Men with a PSA-based Relapse

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

May 28, 2004

In Brief: Lasker Awards; Blobel, Metcalf, Wexler, Rogers; Borch Named Center Director

October 1, 1993

Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer

November 28, 2014

Program Project Payline Is 125; Budget Cuts Will Allow NCI To Fund 49 Competing P01s

February 28, 1992

Reports of SPOREs cut Premature, Broder Says, Wait for Peer Review

March 13, 1992

In Brief: Niederhuber Moves to Sanford As Surgery Chief; Jerome Urban, Breast Specialist, Dead

June 21, 1991